North America’s medical devices industry saw a drop of 27.27% in cross border deal activity in Q3 2022
Led by SD Biosensor and SJL Partners’s $1.54bn private equity deal with Meridian Bioscience, North America’s medical devices industry saw…
Led by SD Biosensor and SJL Partners’s $1.54bn private equity deal with Meridian Bioscience, North America’s medical devices industry saw…